+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug Discovery Services Market Research Report by Type, Drug Type, Process, Therapeutic Area, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5146254
  • Report
  • April 2022
  • Region: Global
  • 218 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Chempartner Co., Ltd.
  • Domainex Ltd.
  • Eurofins Scientific SE
  • Evotec SE
  • Frontage Holdings
  • Jubilant Life Sciences
The Global Drug Discovery Services Market size was estimated at USD 11.71 billion in 2021, USD 13.32 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 13.94% to reach USD 25.63 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Drug Discovery Services to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Biology Services, Drug Metabolism & Pharmacokinetics, and Medicinal Chemistry Services.
  • Based on Drug Type, the market was studied across Biologic Drugs and Small-Molecule Drugs.
  • Based on Process, the market was studied across Candidate Validation, Hit-To-Lead Identification, Lead Optimization, Target Selection, and Target Validation.
  • Based on Therapeutic Area, the market was studied across Cardiovascular Diseases, Digestive System Diseases, Neurology, and Oncology.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Drug Discovery Services market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Drug Discovery Services Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Drug Discovery Services Market, including Albany Molecular Research, Inc., Aurigene Discovery Technologies, Charles River Laboratories International, Chempartner Co., Ltd., Domainex Ltd., Eurofins Scientific SE, Evotec SE, Frontage Holdings, Genscript Biotech Corporation, Jubilant Life Sciences, Laboratory Corporation of America Holdings, Pharmaceutical Product Development, LLC, Piramal Enterprises Limited, Selvita, Shanghai Medicilon, Inc., Syngene International Limited, TCG Lifesciences Pvt. Limited, Thermo Fisher Scientific, Viva Biotech (Shanghai) Ltd., and Wuxi Apptec.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Drug Discovery Services Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Discovery Services Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Discovery Services Market?
4. What is the competitive strategic window for opportunities in the Global Drug Discovery Services Market?
5. What are the technology trends and regulatory frameworks in the Global Drug Discovery Services Market?
6. What is the market share of the leading vendors in the Global Drug Discovery Services Market?
7. What modes and strategic moves are considered suitable for entering the Global Drug Discovery Services Market?
Frequently Asked Questions about the Global Drug Discovery Services Market

What is the estimated value of the Global Drug Discovery Services Market?

The Global Drug Discovery Services Market was estimated to be valued at $11.7 Billion in 2021.

What is the growth rate of the Global Drug Discovery Services Market?

The growth rate of the Global Drug Discovery Services Market is 13.9%, with an estimated value of $25.6 Billion by 2027.

What is the forecasted size of the Global Drug Discovery Services Market?

The Global Drug Discovery Services Market is estimated to be worth $25.6 Billion by 2027.

Who are the key companies in the Global Drug Discovery Services Market?

Key companies in the Global Drug Discovery Services Market include Albany Molecular Research, Inc., Aurigene Discovery Technologies, Charles River Laboratories International, Chempartner Co., Ltd., Domainex Ltd., Eurofins Scientific SE, Evotec SE, Frontage Holdings and Jubilant Life Sciences.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Chempartner Co., Ltd.
  • Domainex Ltd.
  • Eurofins Scientific SE
  • Evotec SE
  • Frontage Holdings
  • Jubilant Life Sciences

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing R&D investments in the pharmaceutical & biopharmaceutical industry
5.1.1.2. Attractive rise in demand for outsourcing analytical testing and clinical trial services
5.1.1.3. Research on rare diseases and orphan drugs
5.1.2. Restraints
5.1.2.1. Expensive drug discovery and development
5.1.3. Opportunities
5.1.3.1. Development in the biologics and focus on drug discovery
5.1.3.2. Potential associated with expiry of patents
5.1.4. Challenges
5.1.4.1. Strict government rules for drug discovery and animal usage
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Drug Discovery Services Market, by Type
6.1. Introduction
6.2. Biology Services
6.3. Drug Metabolism & Pharmacokinetics
6.4. Medicinal Chemistry Services
7. Drug Discovery Services Market, by Drug Type
7.1. Introduction
7.2. Biologic Drugs
7.3. Small-Molecule Drugs
8. Drug Discovery Services Market, by Process
8.1. Introduction
8.2. Candidate Validation
8.3. Hit-To-Lead Identification
8.4. Lead Optimization
8.5. Target Selection
8.6. Target Validation
9. Drug Discovery Services Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Digestive System Diseases
9.4. Neurology
9.5. Oncology
10. Americas Drug Discovery Services Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Drug Discovery Services Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Drug Discovery Services Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Albany Molecular Research, Inc.
14.2. Aurigene Discovery Technologies
14.3. Charles River Laboratories International
14.4. Chempartner Co., Ltd.
14.5. Domainex Ltd.
14.6. Eurofins Scientific SE
14.7. Evotec SE
14.8. Frontage Holdings
14.9. Genscript Biotech Corporation
14.10. Jubilant Life Sciences
14.11. Laboratory Corporation of America Holdings
14.12. Pharmaceutical Product Development, LLC
14.13. Piramal Enterprises Limited
14.14. Selvita
14.15. Shanghai Medicilon, Inc.
14.16. Syngene International Limited
14.17. TCG Lifesciences Pvt. Limited
14.18. Thermo Fisher Scientific
14.19. Viva Biotech (Shanghai) Ltd.
14.20. Wuxi Apptec
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL DRUG DISCOVERY SERVICES MARKET: DYNAMICS
FIGURE 2. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TYPE, 2027
FIGURE 5. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGY SERVICES, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGY SERVICES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG METABOLISM & PHARMACOKINETICS, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG METABOLISM & PHARMACOKINETICS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MEDICINAL CHEMISTRY SERVICES, 2019-2027 (USD BILLION)
FIGURE 10. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MEDICINAL CHEMISTRY SERVICES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 11. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2027
FIGURE 14. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGIC DRUGS, 2019-2027 (USD BILLION)
FIGURE 15. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 16. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL-MOLECULE DRUGS, 2019-2027 (USD BILLION)
FIGURE 17. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL-MOLECULE DRUGS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 18. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2021 VS 2027 (%)
FIGURE 19. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2021 VS 2027 (USD BILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2027
FIGURE 21. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CANDIDATE VALIDATION, 2019-2027 (USD BILLION)
FIGURE 22. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CANDIDATE VALIDATION, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 23. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT-TO-LEAD IDENTIFICATION, 2019-2027 (USD BILLION)
FIGURE 24. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT-TO-LEAD IDENTIFICATION, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 25. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2019-2027 (USD BILLION)
FIGURE 26. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 27. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET SELECTION, 2019-2027 (USD BILLION)
FIGURE 28. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET SELECTION, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 29. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET VALIDATION, 2019-2027 (USD BILLION)
FIGURE 30. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 31. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (%)
FIGURE 32. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (USD BILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2027
FIGURE 34. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2019-2027 (USD BILLION)
FIGURE 35. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 36. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, 2019-2027 (USD BILLION)
FIGURE 37. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 38. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY NEUROLOGY, 2019-2027 (USD BILLION)
FIGURE 39. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 40. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD BILLION)
FIGURE 41. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 42. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 43. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 53. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 67. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 68. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 69. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 70. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 71. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 72. GLOBAL DRUG DISCOVERY SERVICES MARKET: FPNV POSITIONING MATRIX
FIGURE 73. GLOBAL DRUG DISCOVERY SERVICES MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 74. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL DRUG DISCOVERY SERVICES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGY SERVICES, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGY SERVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGY SERVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGY SERVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGY SERVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG METABOLISM & PHARMACOKINETICS, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG METABOLISM & PHARMACOKINETICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG METABOLISM & PHARMACOKINETICS, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG METABOLISM & PHARMACOKINETICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG METABOLISM & PHARMACOKINETICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MEDICINAL CHEMISTRY SERVICES, BY REGION, 2019-2027 (USD BILLION)
TABLE 15. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY MEDICINAL CHEMISTRY SERVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY MEDICINAL CHEMISTRY SERVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 17. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY MEDICINAL CHEMISTRY SERVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY MEDICINAL CHEMISTRY SERVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD BILLION)
TABLE 20. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2019-2027 (USD BILLION)
TABLE 21. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGIC DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 22. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGIC DRUGS, BY STATE, 2019-2027 (USD BILLION)
TABLE 23. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGIC DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGIC DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 25. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL-MOLECULE DRUGS, BY REGION, 2019-2027 (USD BILLION)
TABLE 26. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL-MOLECULE DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 27. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL-MOLECULE DRUGS, BY STATE, 2019-2027 (USD BILLION)
TABLE 28. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL-MOLECULE DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL-MOLECULE DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 30. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2019-2027 (USD BILLION)
TABLE 31. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CANDIDATE VALIDATION, BY REGION, 2019-2027 (USD BILLION)
TABLE 32. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY CANDIDATE VALIDATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 33. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY CANDIDATE VALIDATION, BY STATE, 2019-2027 (USD BILLION)
TABLE 34. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY CANDIDATE VALIDATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY CANDIDATE VALIDATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT-TO-LEAD IDENTIFICATION, BY REGION, 2019-2027 (USD BILLION)
TABLE 37. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT-TO-LEAD IDENTIFICATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 38. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT-TO-LEAD IDENTIFICATION, BY STATE, 2019-2027 (USD BILLION)
TABLE 39. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT-TO-LEAD IDENTIFICATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT-TO-LEAD IDENTIFICATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 41. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2019-2027 (USD BILLION)
TABLE 42. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 43. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY STATE, 2019-2027 (USD BILLION)
TABLE 44. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 46. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET SELECTION, BY REGION, 2019-2027 (USD BILLION)
TABLE 47. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET SELECTION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 48. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET SELECTION, BY STATE, 2019-2027 (USD BILLION)
TABLE 49. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET SELECTION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET SELECTION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 51. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2019-2027 (USD BILLION)
TABLE 52. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET VALIDATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 53. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET VALIDATION, BY STATE, 2019-2027 (USD BILLION)
TABLE 54. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET VALIDATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET VALIDATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 56. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
TABLE 57. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 58. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 59. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 60. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 62. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 63. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 64. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 65. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 67. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 68. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 69. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY NEUROLOGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 70. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 72. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 73. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 74. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 75. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 77. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 78. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 79. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 80. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 81. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 82. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 83. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 84. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 85. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 86. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 87. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 88. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 89. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 90. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 91. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 92. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 93. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 94. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 96. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 97. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 98. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 99. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 100. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 101. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 102. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 103. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 104. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 105. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 106. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 107. GLOBAL DRUG DISCOVERY SERVICES MARKET: SCORES
TABLE 108. GLOBAL DRUG DISCOVERY SERVICES MARKET: BUSINESS STRATEGY
TABLE 109. GLOBAL DRUG DISCOVERY SERVICES MARKET: PRODUCT SATISFACTION
TABLE 110. GLOBAL DRUG DISCOVERY SERVICES MARKET: RANKING
TABLE 111. GLOBAL DRUG DISCOVERY SERVICES MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 112. GLOBAL DRUG DISCOVERY SERVICES MARKET: MERGER & ACQUISITION
TABLE 113. GLOBAL DRUG DISCOVERY SERVICES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 114. GLOBAL DRUG DISCOVERY SERVICES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 115. GLOBAL DRUG DISCOVERY SERVICES MARKET: INVESTMENT & FUNDING
TABLE 116. GLOBAL DRUG DISCOVERY SERVICES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 117. GLOBAL DRUG DISCOVERY SERVICES MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Albany Molecular Research, Inc.
  • Aurigene Discovery Technologies
  • Charles River Laboratories International
  • Chempartner Co., Ltd.
  • Domainex Ltd.
  • Eurofins Scientific SE
  • Evotec SE
  • Frontage Holdings
  • Genscript Biotech Corporation
  • Jubilant Life Sciences
  • Laboratory Corporation of America Holdings
  • Pharmaceutical Product Development, LLC
  • Piramal Enterprises Limited
  • Selvita
  • Shanghai Medicilon, Inc.
  • Syngene International Limited
  • TCG Lifesciences Pvt. Limited
  • Thermo Fisher Scientific
  • Viva Biotech (Shanghai) Ltd.
  • Wuxi Apptec
Note: Product cover images may vary from those shown

Loading
LOADING...